AKT1 | V-akt murine thymoma viral oncogene homolog 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
BCL2L1 | BCL2-like 1 | Cancer-related genes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins RAS pathway related proteins Transporters
| | | | | Expressed in all |
CALM2 | Calmodulin 2 (phosphorylase kinase, delta) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins RAS pathway related proteins Transporters
| | | | | Expressed in all |
CALML5 | Calmodulin-like 5 | Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Group enriched |
CDC42 | Cell division cycle 42 | Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
ELK1 | ELK1, member of ETS oncogene family | Predicted intracellular proteins RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
EPHA2 | EPH receptor A2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
ETS1 | V-ets avian erythroblastosis virus E26 oncogene homolog 1 | Plasma proteins Predicted intracellular proteins RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
FGF2 | Fibroblast growth factor 2 (basic) | Cancer-related genes Candidate cardiovascular disease genes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Mixed |
GNB2 | Guanine nucleotide binding protein (G protein), beta polypeptide 2 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
LAT | Linker for activation of T cells | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
MAP2K2 | Mitogen-activated protein kinase kinase 2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MET | MET proto-oncogene, receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
NFKB1 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
NGFR | Nerve growth factor receptor | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
PAK4 | P21 protein (Cdc42/Rac)-activated kinase 4 | Enzymes Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
PDGFRB | Platelet-derived growth factor receptor, beta polypeptide | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
PIK3CD | Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Mixed |
PIK3R1 | Phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
PLA2G4A | Phospholipase A2, group IVA (cytosolic, calcium-dependent) | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Mixed |
PLD1 | Phospholipase D1, phosphatidylcholine-specific | Enzymes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PRKACA | Protein kinase, cAMP-dependent, catalytic, alpha | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
PRKCA | Protein kinase C, alpha | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
RAB5C | RAB5C, member RAS oncogene family | Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
RASAL3 | RAS protein activator like 3 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
RGL1 | Ral guanine nucleotide dissociation stimulator-like 1 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
ZAP70 | Zeta-chain (TCR) associated protein kinase 70kDa | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |